Recombinant multi-species STK25 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine STK25 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the germinal centre kinase III (GCK III) subfamily of the sterile 20 superfamily of kinases. The encoded enzyme plays a role in serine-threonine liver kinase B1 (LKB1) signaling pathway to regulate neuronal polarization and morphology of the Golgi apparatus. The protein is translocated from the Golgi apparatus to the nucleus in response to chemical anoxia and plays a role in regulation of cell death. A pseudogene associated with this gene is located on chromosome 18. Multiple alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Dec 2012]
The Alternative Names of target: 1500019J11Rik,SOK1,STK25,Serine/threonine-protein kinase 25,Ste20-like,Ste20-like kinase,Ste20/oxidant stress response kinase 1),Sterile 20/oxidant stress-response kinase 1 (SOK-1,Stk25,YSK1,Ysk1

Target products collectionGo to STK25 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP3548-Ag-1/ GM-Tg-hg-IP3548-Ag-2 Human STK25 protein Human
GM-Tg-rg-IP3548-Ag-1/ GM-Tg-rg-IP3548-Ag-2 Rat STK25 protein Rat
GM-Tg-mg-IP3548-Ag-1/ GM-Tg-mg-IP3548-Ag-2 Mouse STK25 protein Mouse
GM-Tg-cynog-IP3548-Ag-1/ GM-Tg-cynog-IP3548-Ag-2 Cynomolgus/Rhesus macaque STK25 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP3548-Ag-1/ GM-Tg-felg-IP3548-Ag-2 Feline STK25 protein Feline
GM-Tg-cang-IP3548-Ag-1/ GM-Tg-cang-IP3548-Ag-2 Canine STK25 protein Canine
GM-Tg-bovg-IP3548-Ag-1/ GM-Tg-bovg-IP3548-Ag-2 Bovine STK25 protein Bovine
GM-Tg-equg-IP3548-Ag-1/ GM-Tg-equg-IP3548-Ag-2 Equine STK25 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP3548-Ag-1/ GM-Tg-hg-IP3548-Ag-2; GM-Tg-rg-IP3548-Ag-1/ GM-Tg-rg-IP3548-Ag-2;
GM-Tg-mg-IP3548-Ag-1/ GM-Tg-mg-IP3548-Ag-2; GM-Tg-cynog-IP3548-Ag-1/ GM-Tg-cynog-IP3548-Ag-2;
GM-Tg-felg-IP3548-Ag-1/ GM-Tg-felg-IP3548-Ag-2; GM-Tg-cang-IP3548-Ag-1/ GM-Tg-cang-IP3548-Ag-2;
GM-Tg-bovg-IP3548-Ag-1/ GM-Tg-bovg-IP3548-Ag-2; GM-Tg-equg-IP3548-Ag-1/ GM-Tg-equg-IP3548-Ag-2
Products Name STK25 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name STK25
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine STK25 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.